News

Recent News About Hesperos and Human-on-a-Chip Technology

future tech Podcast interview with JAMES HICKMAN, PHD, Human-Based Models for Drug Testing

By Hesperos | November 19, 2020 | 0 Comments
Hickman

THE SCIENCE AND TECHNOLOGY PLATFORM THAT COULD

Dr. Hickman Presents Human-on-a-Chip® at Florida Simulation Summit 2020

By Hesperos | November 9, 2020 | 0 Comments
human-on-a-chip

Hesperos Chief Scientist, Dr. James Hickman discusses how a Human-on-a-Chip works at the Florida Simulation Summit 2020

Hesperos listed among 2021 Top Tech Startups in Orlando

By Hesperos | October 15, 2020 | Comments Off on Hesperos listed among 2021 Top Tech Startups in Orlando
hesperos

The Tech Tribune, the journalistic arm of Crunchbase, recently selected Hesperos as one of the top 10 technology startups in Orlando. We are proud to be listed among the best companies in the City Beautiful. Award … Read More

ALS skeletal muscle for a pathologic role

By Hesperos | September 9, 2020 | 0 Comments
ALS

Unraveling the pathologic role of skeletal muscle in ALS A key challenge in developing effective therapies for amyotrophic lateral sclerosis has been a poor understanding of the disease pathology. To address this issue, a team of … Read More

ALS pathology investigated by UCF/Hesperos Researchers Utilizing a Human-on-a-Chip® model

By Hesperos | August 12, 2020 | 0 Comments
als

UCF/HESPEROS RESEARCHERS UTILIZE HUMAN-ON-A-CHIP® APPROACH TO MODEL ALS PATHOLOGY Key Findings Data supports use of functional neuromuscular junction (NMJ) system to evaluate amyotrophic lateral sclerosis pathology  First study to validate the use of Deanna protocol in … Read More

Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response following tissue damage and acute inflammation

By Hesperos | June 2, 2020 | Comments Off on Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response following tissue damage and acute inflammation
hesperos

— New publication in Advanced Science validates potential use in evaluating certain immune responses in drug discovery and systemic diseases, including Coronavirus Disease 2019 (COVID-19)— — Hesperos’ immune system-on-a-chip features recirculating immune cells with the key … Read More

PRECLINICAL STAGES OF ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT MODELED WITH HESPEROS HUMAN-ON-A-CHIP® SYSTEM

By Hesperos | May 28, 2020 | Comments Off on PRECLINICAL STAGES OF ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT MODELED WITH HESPEROS HUMAN-ON-A-CHIP® SYSTEM
Hesperos

PRECLINICAL STAGES OF ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT MODELED WITH HESPEROS HUMAN-ON-A-CHIP® SYSTEM — Peer-reviewed publication in Alzheimer’s & Dementia: Translational Research & Clinical Interventions validates potential of drug discovery platform and ability to study … Read More